Transparency Rising
Insights
Transparency Rising Announces New Name and Next Phase of National Mission to Advance Drug Pricing Innovation and Pharmacy Care Transformation
Organization formerly known as Transparency-Rx has grown to more than 21 members and affiliated companies, representing over 20 million covered lives WASHINGTON, D.C., June 28, 2026 — Transparency Rising, formerly known as Transparency-Rx, today announced its new name and the next phase of its national mission to lower prescription drug costs, build a more competitive pharmacy care marketplace, and establish sound drug policy built on trust, integrity, and insight. In less than four years, Transparency Rising has grown to more than a dozen pharmacy benefit management (PBM) members and a total of 21 affiliated companies, representing more than 20 million covered lives. With a rapidly expanding national footprint, Transparency Rising is led by licensed, transparent PBMs, which are...
Transparency Rising Statement on Federal Trade Commission Lawsuit Against Big PBMs
Transparency Rising applauds the Federal Trade Commission today for bringing federal anti-trust...
Congress Must Enact Comprehensive PBM Reform This Year
Leaders from three leading non-profit business associations issued a united statement on Congress’...
Statement on House Oversight Committee Markup of H.R. 6283 and Inclusion of the Delinking Revenue from Unfair Gouging Act (DRUG Act)
Transparency Rising, a not-for-profit coalition led by transparent pharmacy benefit...
Transparency Rising Welcomes Pharmacy Benefit Dimensions as Newest Member
Transparency-Rx, a not-for-profit coalition led by transparent pharmacy benefit...
APCI and Transparency Rising Unite in Congressional Advocacy for Critical PBM Reforms
The American Pharmacy Cooperative, Inc. (APCI) and Transparency-Rx, a...
Transparency Rising Statement on Senate Finance Committee Passage
Transparency Rising, a new not-for-profit coalition led by transparent pharmacy benefit...
